CXCR4 and neoplasm: For instance, blocking CXCR4 has been shown to reduce the recruitment of MDSCs and regulatory T cells to the tumor site, as these are known to suppress cytotoxic T lymphocytes and hinder effective anti-tumor immune responses [57,58].